Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
NYSE:DGX
Price:
142.78 USD
1.42%
Updated:
May 16, 2024
Quest Diagnostics Inc
Selling, General & Administrative
|
Quest Diagnostics Inc
Selling, General & Administrative Peer Comparison
Comparables:
DVA
CHE
CVS
CI
LH
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Selling, General & Administrative
-$1.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
DaVita Inc
NYSE:DVA
|
Selling, General & Administrative
-$1.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Chemed Corp
NYSE:CHE
|
Selling, General & Administrative
-$377.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
CVS Health Corp
NYSE:CVS
|
Selling, General & Administrative
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Selling, General & Administrative
-$14.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
See Also
What is Quest Diagnostics Inc's Selling, General & Administrative?
Selling, General & Administrative
-1.6B
USD
-1.6B
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Selling, General & Administrative amounts to -1.6B USD.
What is Quest Diagnostics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
0%
0%
Over the last year, the Selling, General & Administrative growth was 11%. The average annual Selling, General & Administrative growth rates for Quest Diagnostics Inc have been -1% over the past three years , -3% over the past five years .
You don't have any saved screeners yet
